$TBBK

Piper Sandler cuts Bancorp stock price target on fintech partner loss

Piper Sandler reduced its price target for The Bancorp Inc. (TBBK) to $75 from $86, citing a 22% stock decline after CHYM's acquisition of Stride Bank ended their partnership. TBBK's stock is near its 52-week low at $50.15, down 25% YTD. The analyst expects 21-31% YOY earnings growth despite revenue loss concerns. TBBK's Q2 earnings beat estimates but revenue missed expectations.

Original reporting
Published Sep 17, 2026, 2:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 2:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$TBBK
Bearish
medium confidence
Mentioned
$TBBK
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$TBBKBearishMed
01

Why it matters

The downgrade signals heightened revenue risk, likely prompting short‑term price pressure.

02

Market read

Analyst action on a mid‑cap bank may influence sector sentiment and trading decisions.

03

What to watch

Potential new fintech partnerships or cost‑cutting measures not yet disclosed.

Relevance 7/10Novelty 6/10Timing: post-market

Background

Analyst price‑target adjustment following partner termination and recent earnings beat.

Company-level read

Ticker impact

$TBBKBearishMedium confidence
Context

Piper Sandler cut The Bancorp's price target to $75 from $86, citing loss of fintech partner CHYM which contributed ~8% of revenue.

Expected impact

Potential short-term downside of 3‑5% as investors reassess revenue exposure.

Evidence & confidence

The target reduction reflects revenue risk; market may react promptly to the new guidance.

Market effects

Fintech‑bank partnership risk highlighted for similar regional banks.

May weigh on US regional banking sector sentiment.

Limited to US banking and fintech ecosystem.

Counterpoint

The Bancorp could benefit from a broader fintech shift, offsetting partner loss.

Key entities

  • The Bancorp Inc.

    US regional bank impacted by fintech partner loss.

  • Piper Sandler

    Equity research firm issuing the price‑target cut.

Related articles

$TBBKHighAI 9/10

Why The Bancorp (TBBK) Stock Is Falling Today

The Bancorp (TBBK) shares dropped 21.3% after Chime announced a $590M acquisition of Stride Bank, raising concerns about consolidating operations away from The Bancorp. Chime plans to move its banking activities to Stride, impacting The Bancorp's transaction volume and fee revenue. The Bancorp's stock is down 25.6% YTD and 37.3% below its 52-week high.

$TBBKHighAI 9/10

Why Is The Bancorp Stock Down 21% Today?

The Bancorp (TBBK) fell 20.9% Wednesday after Chime agreed to buy Stride Bank for $590M, potentially reducing its reliance on The Bancorp. Chime expects $100M+ in cost savings from the deal, which may impact The Bancorp's fintech partnership.

$TBBKHighAI 8/10

Bancorp’s Fintech Comeback Gains Momentum

The Bancorp reported Q2 earnings of $1.45 per share, beating estimates, with fintech fee income and gross dollar volume rising sharply. Criticized loans fell significantly from a year earlier. Analysts hold a Moderate Buy consensus rating with roughly 10% upside. The company continues raising guidance and repurchasing shares to boost per-share growth. The Bancorp operates as a 'banking-as-a-service' sponsor for fintech apps like Chime, PayPal, and Cash App.

$TBBKMedAI 8/10

Bancorp (TBBK) Q2 2026 Earnings Call Transcript

Bancorp (TBBK) discussed its Q2 2026 earnings call, citing fintech GDV growth of 22.5% YoY and fintech revenue growth of 21% YoY. The company raised full-year 2026 EPS guidance to $5.95 to $6.05, with Q4 2026 EPS guidance of $1.65 to $1.75 and 2027 EPS guidance of $8.10 to $8.30. It forecast $200M buybacks in 2026.

$TBBKMed

Why The Bancorp Stock Popped Again Today

The Bancorp (TBBK) shares rose nearly 7% on Monday after two analysts raised price targets following its Q2 earnings. Piper Sandler’s Manuel Navas lifted fair value to $86 from $70 and kept an overweight rating, citing guidance for double-digit EPS growth and ongoing share repurchases. Keefe, Bruyette & Woods raised its target to $79 from $77 and kept a buy-equivalent rating.